Genasense Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced...
Genta Incorporated (OTCBB: GETA.OB) announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company?s lead oncology product, Genasense®...


